Results 271 to 280 of about 230,488 (361)

Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra‐operative detection and translational research

open access: yesBJU International, EarlyView.
Objectives To review the clinical utility, outcome and possible future applications of sentinel lymph node biopsy (SLNB) in penile cancer (PeC), bladder cancer (BCa), prostate cancer (PCa), testicular cancer (TCa) and renal cell carcinoma (RCC), focusing in particular on current SLNB standards and exploring advancements in imaging agents, intra ...
Erik J. van Gennep   +7 more
wiley   +1 more source

Long‐term oncological outcomes of bladder cancer: a population‐based study with a 25‐year follow‐up

open access: yesBJU International, EarlyView.
Objective To describe the oncological outcomes for patients with newly diagnosed bladder cancer, as long‐term oncological outcomes and natural history of different initial subtypes of diagnoses of bladder cancer are understudied. Patients and Methods This was a prospective, multicentre population‐based cohort study, where newly diagnosed patients with ...
Linda Dey   +14 more
wiley   +1 more source

Incidence and risk factors for postoperative vaginal events following radical cystectomy for bladder cancer: a nationwide population‐based study

open access: yesBJU International, EarlyView.
Objective To estimate the probability of vaginal events (diagnosis and/or surgery) following radical cystectomy (RC) and explore possible risk factors in a nationwide population‐based observational registry based study. Patients and Methods Women undergoing RC for urinary bladder cancer in Sweden, from 1 January 1997 to 31 December 2019, were ...
Elin Kalén   +11 more
wiley   +1 more source

Long‐term outcomes of a cascading salvage strategy for high‐risk non‐muscle‐invasive bladder cancer

open access: yesBJU International, EarlyView.
Objective To report long‐term oncological outcomes of patients with high‐risk non‐muscle‐invasive bladder cancer (HR‐NMIBC) undergoing bladder‐sparing therapy (BST) after bacillus Calmette–Guérin (BCG) failure. Patients and Methods We retrospectively reviewed patients with HR‐NMIBC treated from 2000 to 2025 with intravesical therapies after BCG failure,
Ian M. McElree   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy